Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease.

Vilariño-Güell C, Zimprich A, Martinelli-Boneschi F, Herculano B, Wang Z, Matesanz F, Urcelay E, Vandenbroeck K, Leyva L, Gris D, Massaad C, Quandt JA, Traboulsee AL, Encarnacion M, Bernales CQ, Follett J, Yee IM, Criscuoli MG, Deutschländer A, Reinthaler EM, Zrzavy T, Mascia E, Zauli A, Esposito F, Alcina A, Izquierdo G, Espino-Paisán L, Mena J, Antigüedad A, Urbaneja-Romero P, Ortega-Pinazo J, Song W, Sadovnick AD.

PLoS Genet. 2019 Jun 6;15(6):e1008180. doi: 10.1371/journal.pgen.1008180. eCollection 2019 Jun.

2.

Analysis of NOD-like receptor NLRP1 in multiple sclerosis families.

Bernales CQ, Encarnacion M, Criscuoli MG, Yee IM, Traboulsee AL, Sadovnick AD, Vilariño-Güell C.

Immunogenetics. 2018 Mar;70(3):205-207. doi: 10.1007/s00251-017-1034-2. Epub 2017 Oct 7.

PMID:
28988323
3.

Genetic modifiers of multiple sclerosis progression, severity and onset.

Sadovnick AD, Traboulsee AL, Zhao Y, Bernales CQ, Encarnacion M, Ross JP, Yee IM, Criscuoli MG, Vilariño-Güell C.

Clin Immunol. 2017 Jul;180:100-105. doi: 10.1016/j.clim.2017.05.009. Epub 2017 May 10.

PMID:
28501589
4.

Common genetic etiology between "multiple sclerosis-like" single-gene disorders and familial multiple sclerosis.

Traboulsee AL, Sadovnick AD, Encarnacion M, Bernales CQ, Yee IM, Criscuoli MG, Vilariño-Güell C.

Hum Genet. 2017 Jun;136(6):705-714. doi: 10.1007/s00439-017-1784-9. Epub 2017 Mar 23.

PMID:
28337550
5.

Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis.

Sadovnick AD, Gu BJ, Traboulsee AL, Bernales CQ, Encarnacion M, Yee IM, Criscuoli MG, Huang X, Ou A, Milligan CJ, Petrou S, Wiley JS, Vilariño-Güell C.

Hum Mutat. 2017 Jun;38(6):736-744. doi: 10.1002/humu.23218. Epub 2017 Apr 13.

6.

Patient-Reported Benefits of Extracranial Venous Therapy: British Columbia CCSVI Registry.

Sadovnick AD, Yee IM, Attwell-Pope K, Keyes G, Kipp L, Traboulsee AL.

Can J Neurol Sci. 2017 May;44(3):246-254. doi: 10.1017/cjn.2017.27. Epub 2017 Mar 8.

PMID:
28270250
7.

Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.

Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M, Yee IM, de Lemos M, Greenwood T, Lee JD, Wright G, Ross CJ, Zhang S, Song W, Vilariño-Güell C.

Neuron. 2016 Oct 19;92(2):555. doi: 10.1016/j.neuron.2016.09.028. No abstract available.

8.

Case-Control Studies Are Not Familial Studies.

Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M, Yee IM, de Lemos M, Greenwood T, Lee JD, Wright G, Ross CJ, Zhang S, Song W, Vilariño-Güell C.

Neuron. 2016 Oct 19;92(2):339-341. doi: 10.1016/j.neuron.2016.09.053.

9.

Editorial Note to:Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.

Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M, Yee IM, de Lemos M, Greenwood T, Lee JD, Wright G, Ross CJ, Zhang S, Song W, Vilariño-Güell C.

Neuron. 2016 Oct 19;92(2):331-332. doi: 10.1016/j.neuron.2016.10.008. No abstract available.

10.

Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.

Wang Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M, Yee IM, de Lemos M, Greenwood T, Lee JD, Wright G, Ross CJ, Zhang S, Song W, Vilariño-Güell C.

Neuron. 2016 Jun 1;90(5):948-54. doi: 10.1016/j.neuron.2016.04.039. Erratum in: Neuron. 2016 Oct 19;92(2):555.

11.

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.

Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antigüedad A, Vandenbroeck K, Akkad DA, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen JT, Gerdes LA, Kroner A, Kubisch C, Kümpfel T, Lohse P, Rieckmann P, Zettl UK, Zipp F, Bertram L, Lill CM, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeño JC, Arroyo R, Garagorri AM, García-Martínez A, Villar LM, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied MC, Zimprich A, Vilariño-Güell C.

G3 (Bethesda). 2016 Jul 7;6(7):2073-9. doi: 10.1534/g3.116.030841.

12.

Analysis of CH25H in multiple sclerosis and neuromyelitis optica.

Forwell AL, Bernales CQ, Ross JP, Yee IM, Encarnacion M, Lee JD, Sadovnick AD, Traboulsee AL, Vilariño-Güell C.

J Neuroimmunol. 2016 Feb 15;291:70-2. doi: 10.1016/j.jneuroim.2015.12.014. Epub 2015 Dec 31.

13.

Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.

Lee JD, Guimond C, Yee IM, Vilariño-Güell C, Wu ZY, Traboulsee AL, Sadovnick AD.

Can J Neurol Sci. 2015 Jul;42(4):235-41. doi: 10.1017/cjn.2015.36. Epub 2015 Jun 15.

PMID:
26074012
14.

The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.

Hader WJ, Yee IM.

Mult Scler Int. 2014;2014:545080. doi: 10.1155/2014/545080. Epub 2014 Feb 3.

15.

Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors.

Guimond C, Lee JD, Ramagopalan SV, Dyment DA, Hanwell H, Giovannoni G, Criscuoli M, Yee IM, Vorobeychik G, Ebers GC, Sadovnick AD.

Mult Scler. 2014 Aug;20(9):1182-8. doi: 10.1177/1352458513519179. Epub 2014 Jan 10.

PMID:
24414537
16.

Multiple sclerosis and pregnancy: a comparison study.

Alwan S, Dybalski M, Yee IM, Greenwood TM, Roger E, Nadeau N, Duquette P, Sadovnick AD.

Can J Neurol Sci. 2013 Jul;40(4):590-6.

PMID:
23786746
17.

Association of smoking with risk of multiple sclerosis: a population-based study.

Ramagopalan SV, Lee JD, Yee IM, Guimond C, Traboulsee AL, Ebers GC, Sadovnick AD.

J Neurol. 2013 Jul;260(7):1778-81. doi: 10.1007/s00415-013-6873-7. Epub 2013 Mar 2.

PMID:
23455932
18.

Reproductive decision making after the diagnosis of multiple sclerosis (MS).

Alwan S, Yee IM, Dybalski M, Guimond C, Dwosh E, Greenwood TM, Butler R, Sadovnick AD.

Mult Scler. 2013 Mar;19(3):351-8. doi: 10.1177/1352458512452920. Epub 2012 Jul 3.

PMID:
22760102
19.

Early life child exposure and the risk of multiple sclerosis: a population based study.

Ramagopalan SV, Guimond C, Dyment DA, Yee IM, Ebers GC, Sadovnick AD.

J Neurol Sci. 2011 Aug 15;307(1-2):162-3. doi: 10.1016/j.jns.2011.04.014. Epub 2011 May 23.

PMID:
21601888
20.

Congenital abnormalities and multiple sclerosis.

Ramagopalan SV, Guimond C, Criscuoli M, Dyment DA, Orton SM, Yee IM, Ebers GC, Sadovnick D.

BMC Neurol. 2010 Nov 16;10:115. doi: 10.1186/1471-2377-10-115.

21.

Childhood cow's milk allergy and the risk of multiple sclerosis: a population based study.

Ramagopalan SV, Dyment DA, Guimond C, Orton SM, Yee IM, Ebers GC, Sadovnick AD.

J Neurol Sci. 2010 Apr 15;291(1-2):86-8. doi: 10.1016/j.jns.2009.10.021. Epub 2010 Jan 21.

PMID:
20096420
22.

No effect of parental age on risk of multiple sclerosis: a population-based study.

Ramagopalan SV, Dyment DA, Guimond C, Yee IM, Ebers GC, Sadovnick AD.

Neuroepidemiology. 2010;34(2):106-9. doi: 10.1159/000268822. Epub 2009 Dec 24.

PMID:
20051693
23.

Prevalence of MS in Iranian immigrants to British Columbia, Canada.

Guimond C, Dyment DA, Ramagopalan SV, Giovannoni G, Criscuoli M, Yee IM, Ebers GC, Sadovnick AD.

J Neurol. 2010 Apr;257(4):667-8. doi: 10.1007/s00415-009-5417-7. Epub 2009 Dec 10. No abstract available.

PMID:
20012309
24.

Sex ratio of multiple sclerosis and clinical phenotype.

Ramagopalan SV, Byrnes JK, Orton SM, Dyment DA, Guimond C, Yee IM, Ebers GC, Sadovnick AD.

Eur J Neurol. 2010 Apr;17(4):634-7. doi: 10.1111/j.1468-1331.2009.02850.x. Epub 2009 Nov 24.

PMID:
19968710
25.

Mother-child blood group incompatibility and the risk of multiple sclerosis.

Ramagopalan SV, Dyment DA, Guimond C, Orton SM, Yee IM, Ebers GC, Sadovnick AD.

J Neurol. 2010 Feb;257(2):286-7. doi: 10.1007/s00415-009-5325-x. Epub 2009 Oct 1. No abstract available.

PMID:
19795153
26.

Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study.

Orton SM, Ramagopalan SV, Brocklebank D, Herrera BM, Dyment DA, Yee IM, Sadovnick AD, Ebers GC.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):31-6. doi: 10.1136/jnnp.2008.162784. Epub 2009 Aug 25.

27.

Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.

Ramagopalan SV, Byrnes JK, Dyment DA, Guimond C, Handunnetthi L, Disanto G, Yee IM, Ebers GC, Sadovnick AD.

J Hum Genet. 2009 Sep;54(9):547-9. doi: 10.1038/jhg.2009.69. Epub 2009 Jul 24.

PMID:
19629136
28.

Age of onset in concordant twins and other relative pairs with multiple sclerosis.

Sadovnick AD, Yee IM, Guimond C, Reis J, Dyment DA, Ebers GC.

Am J Epidemiol. 2009 Aug 1;170(3):289-96. doi: 10.1093/aje/kwp143. Epub 2009 Jun 22.

29.

Parent-of-origin effect in multiple sclerosis: observations from interracial matings.

Ramagopalan SV, Yee IM, Dyment DA, Orton SM, Marrie RA, Sadovnick AD, Ebers GC; Canadian Collaborative Study Group.

Neurology. 2009 Aug 25;73(8):602-5. doi: 10.1212/WNL.0b013e3181af33cf. Epub 2009 Jun 10.

30.

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, Giovannoni G, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

Neuroepidemiology. 2009;32(4):257-62. doi: 10.1159/000201564. Epub 2009 Feb 11.

PMID:
19209005
31.

Age of puberty and the risk of multiple sclerosis: a population based study.

Ramagopalan SV, Valdar W, Criscuoli M, DeLuca GC, Dyment DA, Orton SM, Yee IM, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

Eur J Neurol. 2009 Mar;16(3):342-7. doi: 10.1111/j.1468-1331.2008.02431.x.

PMID:
19170744
32.

No effect of birth weight on the risk of multiple sclerosis. A population-based study.

Ramagopalan SV, Herrera BM, Valdar W, Dyment DA, Orton SM, Yee IM, Criscuoli M, Atkins K, Ebers GC, Sadovnick AD.

Neuroepidemiology. 2008;31(3):181-4. doi: 10.1159/000154931. Epub 2008 Sep 11.

PMID:
18784417
33.

No effect of preterm birth on the risk of multiple sclerosis: a population based study.

Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Orton SM, Yee IM, Criscuoli M, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

BMC Neurol. 2008 Aug 1;8:30. doi: 10.1186/1471-2377-8-30.

34.

Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.

Hader WJ, Yee IM.

Neurology. 2007 Sep 18;69(12):1224-9.

PMID:
17875910
35.

A timing-of-birth effect on multiple sclerosis clinical phenotype.

Sadovnick AD, Duquette P, Herrera B, Yee IM, Ebers GC.

Neurology. 2007 Jul 3;69(1):60-2.

PMID:
17606881
36.

Parental transmission of MS in a population-based Canadian cohort.

Herrera BM, Ramagopalan SV, Orton S, Chao MJ, Yee IM, Sadovnick AD, Ebers GC.

Neurology. 2007 Sep 18;69(12):1208-12. Epub 2007 Jun 27.

PMID:
17596583
37.

Autoimmune disease in families with multiple sclerosis: a population-based study.

Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, Yee IM, Sadovnick AD, Ebers GC; Canadian Collaborative Study Group.

Lancet Neurol. 2007 Jul;6(7):604-10.

PMID:
17560172
38.

Clustering of autoimmune disease in families at high risk for multiple sclerosis?

Ramagopalan SV, Dyment DA, Herrera BM, Criscuoli M, Yee IM, Sadovnick AD, Ebers GC.

Lancet Neurol. 2007 Mar;6(3):206-7; author reply 207. No abstract available.

PMID:
17303524
39.

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC; Canadian Collaborative Study Group.

Lancet Neurol. 2006 Nov;5(11):932-6.

PMID:
17052660
40.

Multiple sclerosis in stepsiblings: recurrence risk and ascertainment.

Dyment DA, Yee IM, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):258-9.

41.

Multiple sclerosis and birth order: a longitudinal cohort study.

Sadovnick AD, Yee IM, Ebers GC; Canadian Collaborative Study Group.

Lancet Neurol. 2005 Oct;4(10):611-7.

PMID:
16168929
42.

Parent-of-origin effect in multiple sclerosis: observations in half-siblings.

Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch N.

Lancet. 2004 May 29;363(9423):1773-4.

PMID:
15172777
43.

Multiple sclerosis in Northern Sardinia, Italy: a methodological approach for genetic epidemiological studies.

Pugliatti M, Sotgiu S, Sadovnick AD, Yee IM, Sotgiu MA, Poser CM, Rosati G.

Neuroepidemiology. 2003 Nov-Dec;22(6):362-5.

PMID:
14557688
44.

Recurrence risks to sibs of MS index cases: impact of consanguineous matings.

Dessa Sadovnick A, Yee IM, Ebers GC; Canadian Collaborative Study Group.

Neurology. 2001 Mar 27;56(6):784-5.

PMID:
11274317
45.

Factors influencing sib risks for multiple sclerosis.

Sadovnick AD, Yee IM, Ebers GC; Canadian Collaborative Study Group.

Clin Genet. 2000 Dec;58(6):431-5.

PMID:
11149611
46.
47.

Effect of age at onset and parental disease status on sibling risks for MS.

Sadovnick AD, Yee IM, Ebers GC, Risch NJ.

Neurology. 1998 Mar;50(3):719-23.

PMID:
9521263
48.

Risks of multiple sclerosis in relatives of patients in Flanders, Belgium.

Carton H, Vlietinck R, Debruyne J, De Keyser J, D'Hooghe MB, Loos R, Medaer R, Truyen L, Yee IM, Sadovnick AD.

J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):329-33.

49.

Major depression, minor depression, and double depression: are they distinct clinical entities?

Remick RA, Sadovnick AD, Lam RW, Zis AP, Yee IM.

Am J Med Genet. 1996 Jul 26;67(4):347-53.

PMID:
8837701
50.

Depression and multiple sclerosis.

Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW.

Neurology. 1996 Mar;46(3):628-32.

PMID:
8618657

Supplemental Content

Support Center